OLMA Smart Money
Olema Pharmaceuticals, Inc.
1W: -2.9%
1M: -18.2%
3M: -37.1%
YTD: -72.2%
1Y: -12.3%
3Y: -33.5%
5Y: -73.7%
$7.04
+0.42 (+6.34%)
Weekly Expected Move ±7.9%
$5
$6
$6
$7
$7
Credit Risk of going bust: lower than 55% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Olema Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $660K against a stock market value of $616.0M.
Distance to default 5.59 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $660K (short-term plus half of long-term), stock volatility 112.1%; Altman Z'' 6.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Olema Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $660K against a stock market value of $616.0M.
Distance to default 5.59 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $660K (short-term plus half of long-term), stock volatility 112.1%; Altman Z'' 6.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026224
Institutions Holding
-23 vs prior
206.4%
Ownership
-36.45%
27
New
73
Increased
93
Reduced
33
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Harmon Cyrus | director | S-Sale | 12,500 | $11.71 | $146K | Filing |
| 2026-07-23 | Harmon Cyrus | director | S-Sale | 12,500 | $11.58 | $145K | Filing |
| 2026-03-04 | Mitchell Shawnte | officer: chief legal officer | S-Sale | 233 | $24.69 | $6K | Filing |
| 2026-03-04 | Mitchell Shawnte | officer: chief legal officer | S-Sale | 24,767 | $24.25 | $601K | Filing |
| 2026-03-03 | Mitchell Shawnte | officer: chief legal officer | S-Sale | 15,000 | $23.01 | $345K | Filing |
| 2026-02-02 | Austin Sasha Lu | officer: vp of finance and controller | A-Grant/Award | 11,700 | $— | $0 | Filing |
| 2026-01-20 | Harmon Cyrus | director | S-Sale | 10,000 | $26.88 | $269K | Filing |
| 2026-01-15 | Kovacs Shane William Charles | officer: ch. operating & financial off. | S-Sale | 100,000 | $28.73 | $2.9M | Filing |
| 2026-01-14 | Harmon Cyrus | director | S-Sale | 3,489 | $29.12 | $102K | Filing |
| 2026-01-14 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 14,997 | $28.60 | $429K | Filing |
| 2026-01-14 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 35,003 | $28.99 | $1.0M | Filing |
| 2026-01-13 | Kovacs Shane William Charles | officer: ch. operating & financial off. | S-Sale | 3,822 | $28.01 | $107K | Filing |
| 2026-01-13 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 49,800 | $27.60 | $1.4M | Filing |
| 2026-01-13 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 200 | $28.49 | $6K | Filing |
| 2026-01-12 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 10,000 | $28.34 | $283K | Filing |
| 2025-12-26 | Bohen Sean | officer: president and ceo | G-Gift | 8,500 | $— | $0 | Filing |
| 2025-12-23 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 99,509 | $27.66 | $2.8M | Filing |
| 2025-12-22 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 100,000 | $28.04 | $2.8M | Filing |
| 2025-12-22 | Harmon Cyrus | director | S-Sale | 2,881 | $28.53 | $82K | Filing |
| 2025-12-19 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 57,079 | $28.03 | $1.6M | Filing |
| 2025-12-19 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 12,921 | $28.93 | $374K | Filing |
| 2025-12-19 | CLARK IAN T | director | S-Sale | 41,840 | $30.48 | $1.3M | Filing |
| 2025-12-19 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 43,729 | $30.40 | $1.3M | Filing |
| 2025-12-19 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 1,225 | $28.08 | $34K | Filing |
| 2025-12-19 | CLARK IAN T | director | S-Sale | 29,904 | $28.83 | $862K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 12,143,062 | $152M | +1,756,217 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 8,670,576 | $108M | +650,000 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 7,094,413 | $89M | +7,094,413 | 2026-06-30 | Filing |
| Bain Capital Life Sciences Investors, LL | 7,085,249 | $89M | -387,989 | 2026-06-30 | Filing |
| BlackRock, Inc. | 6,714,691 | $84M | +1,062,556 | 2026-06-30 | Filing |
| BVF INC/IL | 5,295,893 | $66M | — | 2026-06-30 | Filing |
| Siren, L.L.C. | 4,856,949 | $61M | +100,000 | 2026-06-30 | Filing |
| STATE STREET CORP | 4,316,058 | $54M | +378,227 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,341,217 | $42M | +257,700 | 2026-06-30 | Filing |
| Logos Global Management LP | 3,208,875 | $40M | — | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 2,349,586 | $29M | +1,130,629 | 2026-06-30 | Filing |
| Cormorant Asset Management, LP | 2,150,000 | $27M | -1,750,000 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,832,269 | $23M | +616,579 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,819,029 | $23M | +274,612 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,663,218 | $21M | +1,070,187 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,567,979 | $20M | +522,390 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 1,500,000 | $19M | +1,500,000 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,416,533 | $18M | +334,099 | 2026-06-30 | Filing |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1,355,299 | $17M | — | 2026-06-30 | Filing |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,200,000 | $15M | +345,000 | 2026-06-30 | Filing |